UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Comparative Study of the Hypoxia PET Tracers [18 F]HX4, [18 F]FAZA, and [18 F]FMISO in a Preclinical Tumor Model

International journal of radiation oncology, biology, physics, 2015-02, Vol.91 (2), p.351-359

2015

Volltextzugriff (PDF)

State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET

Bioconjugate chemistry, 2021-07, Vol.32 (7), p.1315-1330

2021

Volltextzugriff (PDF)

Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)

PloS one, 2014-01, Vol.9 (1), p.e82331

2014

Volltextzugriff (PDF)

PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non-Small Cell Lung Cancer

Journal of Nuclear Medicine, 2022-05, Vol.63 (5), p.686-693

2022

Volltextzugriff (PDF)

Improving Tumor Penetration of Antibodies and Antibody-Drug Conjugates: Taking Away the Barriers for Trojan Horses

Cancer research (Chicago, Ill.), 2021-08, Vol.81 (15), p.3956-3957

van Dongen, Guus A M S

2021

Volltextzugriff (PDF)

Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p -isothiocyanatobenzyl-desferrioxamine

Nature protocols, 2010-04, Vol.5 (4), p.739-743

2010

Volltextzugriff (PDF)

PET‐CT Imaging of Polymeric Nanoparticle Tumor Accumulation in Patients

Advanced materials (Weinheim), 2022-05, Vol.34 (21), p.e2201043-n/a

2022

Volltextzugriff (PDF)

Immuno‐PET: A Navigator in Monoclonal Antibody Development and Applications

The oncologist (Dayton, Ohio), 2007-12, Vol.12 (12), p.1379-1389

2007

Volltextzugriff (PDF)

α‐Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives

Movement disorders, 2022-05, Vol.37 (5), p.936-948

2022

Volltextzugriff (PDF)

A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus

Clinical cancer research, 2006-10, Vol.12 (20), p.6064-6072

2006

Volltextzugriff (PDF)

The novel AML stem cell–associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells

Blood, 2007-10, Vol.110 (7), p.2659-2666

2007

Volltextzugriff (PDF)

A biparatopic anti‐EGFR nanobody efficiently inhibits solid tumour growth

International journal of cancer, 2011-10, Vol.129 (8), p.2013-2024

2011

Volltextzugriff (PDF)

An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates

Angewandte Chemie International Edition, 2021-02, Vol.60 (6), p.3008-3015

International ed. in English, 2021

Volltextzugriff (PDF)

Nanobodies targeting the hepatocyte growth factor: potential new drugs for molecular cancer therapy

Molecular cancer therapeutics, 2012-04, Vol.11 (4), p.1017-1025

2012

Volltextzugriff (PDF)

Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo

The Journal of biological chemistry, 2013-10, Vol.288 (41), p.29562-29572

2013

Volltextzugriff (PDF)

A successful search for new, efficient, and silver-free manufacturing processes for key platinum() intermediates applied in antibody-drug conjugate (ADC) production

Green chemistry : an international journal and green chemistry resource : GC, 2020-04, Vol.22 (7), p.223-2212

2020

Volltextzugriff (PDF)

The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors

International journal of molecular sciences, 2020-02, Vol.21 (3), p.1029

2020

Volltextzugriff (PDF)

Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β

European journal of nuclear medicine and molecular imaging, 2024-10, Vol.51 (12), p.3545-3558

2024

Volltextzugriff (PDF)

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging

European journal of nuclear medicine and molecular imaging, 2010-02, Vol.37 (2), p.250-259

2010

Volltextzugriff (PDF)

PET imaging with small-molecule tyrosine kinase inhibitors: TKI-PET

Drug discovery today, 2012-11, Vol.17 (21-22), p.1175-1187

2012

Volltextzugriff (PDF)

The Human Cytomegalovirus―Encoded Chemokine Receptor US28 Promotes Angiogenesis and Tumor Formation via Cyclooxygenase-2

Cancer research (Chicago, Ill.), 2009-04, Vol.69 (7), p.2861-2869

2009

Volltextzugriff (PDF)

Human Cytomegalovirus-Encoded Chemokine Receptor US28 Promotes Tumorigenesis

Proceedings of the National Academy of Sciences - PNAS, 2006-08, Vol.103 (35), p.13068-13073

2006

Volltextzugriff (PDF)

Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?

Frontiers in pharmacology, 2016-05, Vol.7, p.131-131

2016

Volltextzugriff (PDF)

Investigation of the Impact of the H310A FcRn Region Mutation on 89Zr-Immuno-PET Brain Imaging with a BBB-Shuttle Anti‑Amyloid Beta Antibody

Molecular imaging and biology, 2024, Vol.26 (5), p.823-834

2024

Volltextzugriff (PDF)

89Zr-Labeled High-Density Lipoprotein Nanoparticle PET Imaging Reveals Tumor Uptake in Patients with Esophageal Cancer

The Journal of nuclear medicine (1978), 2022-12, Vol.63 (12), p.1880-1886

2022

Volltextzugriff (PDF)

1 – 25 von 336

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(321)
Mit Volltextzugriff
(318)

Publikationsform

Sprache

Englisch
(336)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(136)
Science & Technology
(130)
Life Sciences & Biomedicine
(124)
Animals
(98)
Mice
(77)
Oncology
(76)
Tumors
(69)
Biological And Medical Sciences
(67)
Female
(65)
Medical Sciences
(63)
Tissue Distribution
(48)
Monoclonal Antibodies
(46)
Male
(41)
Mice, Nude
(41)
Nuclear Medicine
(39)
Positron-Emission Tomography - Methods
(38)
Radiology, Nuclear Medicine & Medical Imaging
(37)
Tomography
(37)
Imaging
(36)
Antibodies, Monoclonal - Pharmacokinetics
(33)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A Comparative Study of the Hypoxia PET Tracers [18 F]HX4, [18 F]FAZA, and [18 F]FMISO in a Preclinical Tumor Model

State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET

Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)

PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non-Small Cell Lung Cancer

Improving Tumor Penetration of Antibodies and Antibody-Drug Conjugates: Taking Away the Barriers for Trojan Horses

Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p -isothiocyanatobenzyl-desferrioxamine

PET‐CT Imaging of Polymeric Nanoparticle Tumor Accumulation in Patients

Immuno‐PET: A Navigator in Monoclonal Antibody Development and Applications

α‐Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives

A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus

The novel AML stem cell–associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells

A biparatopic anti‐EGFR nanobody efficiently inhibits solid tumour growth

An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates

Nanobodies targeting the hepatocyte growth factor: potential new drugs for molecular cancer therapy

Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo

A successful search for new, efficient, and silver-free manufacturing processes for key platinum() intermediates applied in antibody-drug conjugate (ADC) production

The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors

Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging

PET imaging with small-molecule tyrosine kinase inhibitors: TKI-PET

The Human Cytomegalovirus―Encoded Chemokine Receptor US28 Promotes Angiogenesis and Tumor Formation via Cyclooxygenase-2

Human Cytomegalovirus-Encoded Chemokine Receptor US28 Promotes Tumorigenesis

Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?

Investigation of the Impact of the H310A FcRn Region Mutation on 89Zr-Immuno-PET Brain Imaging with a BBB-Shuttle Anti‑Amyloid Beta Antibody

89Zr-Labeled High-Density Lipoprotein Nanoparticle PET Imaging Reveals Tumor Uptake in Patients with Esophageal Cancer

Suchergebnisse filtern